Balyasny Asset Management’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-87,200
Closed -$730K 2683
2023
Q2
$730K Sell
87,200
-153,900
-64% -$1.6M ﹤0.01% 1742
2023
Q1
$3.05M Buy
241,100
+57,500
+31% +$665K 0.01% 1281
2022
Q4
$1.67M Buy
183,600
+63,900
+53% +$690K ﹤0.01% 1482
2022
Q3
$1.41M Sell
119,700
-35,900
-23% -$454K ﹤0.01% 1667
2022
Q2
$2M Buy
+155,600
New +$2.08M 0.01% 1395

Other funds holding SKIN

Balyasny Asset Management's SKIN Position: Q3 2023 in Review

Balyasny Asset Management sold out of SkinHealth Systems (SKIN) in Q3 2023, closing a stake of 201,100 shares — an estimated $1.68M sold.

Balyasny Asset Management first reported a position in SKIN in Q3 2021 and held it in 5 quarters. The position peaked at $11.2M in Q3 2021. 135 funds tracked by Wall St. Rank hold SKIN as of Q3 2023.

  • Balyasny Asset Management reported no remaining SkinHealth Systems position as of Q3 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 201,100 SkinHealth Systems shares in Q3 2023, an estimated $1.68M.
  • Balyasny Asset Management first reported a position in SkinHealth Systems in Q3 2021 and held it in 5 quarters.
  • Balyasny Asset Management's SkinHealth Systems position peaked at $11.2M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.